Search

Displaying results 7741 - 7750 of 10000 in total
  1. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    Xininurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor.

  2. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    Ansornitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor.

  3. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    Garsorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  4. Drug

    Gumelutamide

    go.drugbank.com/drugs/DB21615
    Experimental

    Gumelutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen.

  5. Drug

    Frevecitinib

    go.drugbank.com/drugs/DB21681
    Investigational

    Frevecitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor.

  6. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    Odentegravir is a small molecule drug. The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor.

  7. Drug

    Enibarcimab

    go.drugbank.com/drugs/DB16730
    Investigational

    Enibarcimab is under investigation in clinical trial NCT03989531 (Adrecizumab in Cardiogenic Shock).

  8. Drug

    Capadenoson

    go.drugbank.com/drugs/DB16118
    Investigational

    Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).

  9. Drug

    Pegademase

    go.drugbank.com/drugs/DB00061
    ApprovedWithdrawn

    Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life.

  10. Drug

    Surzebiclimab

    go.drugbank.com/drugs/DB16669
    Investigational

    Surzebiclimab is under investigation in clinical trial NCT03744468 (Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors).